INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1676137801 facility design, warehouse]( "Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction")
Five Ways Centralized Trial Finance Improves Site And Patient SatisfactionCentralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.
-
![Diversity-GettyImages-1406072634]( "Ensuring A Diverse Patient Population In Clinical Trials")
Ensuring A Diverse Patient Population In Clinical TrialsIn 2025, the FDA will require pharmaceutical companies to include diversity action plans (DAPs) for Phase II and pivotal studies.
-
![GettyImages-1819626829 patient recruitment]( "Clinical Trial Design Strategies To Improve Patient Retention")
Clinical Trial Design Strategies To Improve Patient RetentionWhile clinical trial planning often emphasizes rapid enrollment, sustained patient retention is equally vital to success.
-
![GettyImages-1731147638 research, cell culture]( "Gene, Cell, And RNA Therapy Landscape Continues To Thrive")
Gene, Cell, And RNA Therapy Landscape Continues To ThriveThe horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.
-
Expectations For Plain Language Summaries Continue To Evolve11/7/2025
Plain language summaries (PLS) are growing in importance as a requirement in global transparency. Focusing on protocol and results summaries, we cover expectations and best practices for global PLS implementation.
-
Unique IRT Implementation Considerations For Personalized Medicine Trials8/22/2025
The rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.
-
Mid-Study Randomization: Ensuring Data Integrity In Oncology Trials7/5/2026
Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.
-
Continuous Passive Monitoring's Effect On Sleep Disorder Research3/16/2026
Bridge the gap between clinical sleep studies and real-world behavior. Use continuous, wearable-enabled data to objectively measure daytime sleepiness and improve sleep disorder research.
-
5 RWE Approaches That Strengthen Precision Oncology3/31/2026
Real-world evidence is becoming vital in precision oncology. Discover five creative, practical ways sponsors can use RWE to fuel development, sharpen regulatory strategy, and strengthen market access.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Woman taking medications-GettyImages-1782441970]( "Decentralized Trials Support: Direct-To-Patient Supply Management")
Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.
-
![GettyImages-2189405678-GLP-1-obesity]( "Precision Partnership For Obesity Clinical Trials")
Accelerate obesity research with specialized expertise in GLP-1 trials. Our approach ensures rapid enrollment, high participant retention, and clean data through a patient-centered model.
-
![GettyImages-1819626829 patient recruitment]( "Accelerating Patient Recruitment In Oncology Since 2005")
CSSi is a global, full-service company offering customized services to support recruitment and retention programs around the world.
-
![GettyImages-1483234004-opthalmology-machine-eye-exam]( "Post-Marketing Studies And Real-World Evidence Clinical Trials")
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
-
![iStock-187467661-quality-control-inspection]( "Navigating The Use Of Controlled Substances In Clinical Trials Using IRT")
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
